Grootste U.S. Pharmaceuticals & Biotech aandelen volgens marktkap

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

UPDATED Jun 02, 2026

Ontdek bedrijven met een grote beurskapitalisatie U.S. Pharmaceuticals & Biotech die op de NYSE en NASDAQ staan. Deze Pharmaceuticals & Biotech Companies zijn gerangschikt op Market Cap.

710 bedrijven

Bedrijf	Laatste prijs	7D Terugkeer	1 J Rendement	Marktkapitalisatie	Doel analisten	Waardering	Groei	Div Opbrengst
LLY	US$1,064.15	-0.06%	41.7%	US$965.0b	US$1,215.10	37.5	16.4%	0.7%
JNJ	US$222.89	-3.2%	44.3%	US$538.0b	US$252.87	25.5	8.3%	2.4%
ABBV	US$215.40	1.1%	15.0%	US$376.2b	US$252.90	105.9	25.2%	3.2%
MRK	US$115.65	-3.4%	49.9%	US$284.4b	US$129.74	32.0	21.2%	2.9%
TMO	US$482.08	7.6%	20.5%	US$183.6b	US$607.96	26.2	10.4%	0.4%
AMGN	US$328.26	-2.3%	13.4%	US$177.6b	US$352.23	22.7	8.6%	3.1%
GILD	US$127.57	-4.6%	16.7%	US$162.8b	US$157.83	17.2	21.1%	2.6%
PFE	US$25.55	-1.2%	9.4%	US$146.1b	US$29.19	19.5	-1.0%	6.7%
DHR	US$176.11	1.9%	-8.3%	US$127.3b	US$246.09	33.9	18.7%	0.9%
BMY	US$54.46	-6.2%	13.2%	US$112.2b	US$63.08	15.3	-1.8%	4.6%
VRTX	US$425.09	-2.5%	-4.8%	US$111.3b	US$548.69	24.9	13.0%	n/a
REGN	US$602.92	-5.0%	23.6%	US$61.1b	US$833.31	13.9	11.7%	0.6%
TEVA	US$33.08	-4.4%	92.4%	US$40.3b	US$41.27	24.6	15.4%	0%
ALNY	US$286.12	-3.2%	-5.8%	US$39.5b	US$445.81	71.0	28.3%	n/a
A	US$135.05	17.4%	19.8%	US$38.4b	US$161.94	27.0	12.4%	0.8%
WAT	US$371.93	9.8%	6.5%	US$37.1b	US$399.33	81.2	25.3%	n/a
RVMD	US$151.31	-2.3%	272.9%	US$34.8b	US$186.33	21.4	60.6%	n/a
ZTS	US$76.39	-4.8%	-55.1%	US$32.5b	US$124.59	12.0	5.2%	2.8%
RPRX	US$54.01	0.3%	62.2%	US$31.8b	US$59.25	29.0	38.8%	1.7%
NTRA	US$212.61	5.8%	32.8%	US$31.3b	US$260.06	12.2	61.3%	n/a
IQV	US$180.64	11.5%	26.5%	US$31.2b	US$228.60	21.8	13.1%	n/a
ONC	US$274.69	-9.2%	9.1%	US$31.1b	US$411.91	59.5	29.0%	n/a
BIIB	US$188.83	-2.2%	43.2%	US$28.4b	US$219.44	20.3	13.8%	n/a
ILMN	US$162.55	11.9%	98.6%	US$24.9b	US$143.83	28.8	9.9%	n/a

Page 1 of 30